| Identification | Back Directory | [Name]
BIBN 4096BS | [CAS]
204697-65-4 | [Synonyms]
BIBN-4096
Olcegepant
BIBN 4096BS
BIBN 4096BS API Olcegepant
1-[3,5-Dibromo-N-[[4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl)-1-piperidinyl]carbonyl]-D-tyrosyl-L-lysyl]-4-(4-pyridinyl)-piperazine
Piperazine, 1-[3,5-dibromo-N-[[4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl)-1-piperidinyl]carbonyl]-D-tyrosyl-L-lysyl]-4-(4-pyridinyl)-
N-[2-[5-Amino-1(S)-[4-(4-pyridinyl)piperazin-1-ylcarbonyl]pentylamino]-1(R)-(3,5-dibromo-4-hydroxybenzyl)-2-oxoethyl]-4-(2-oxo-1,2,3,4-tetrahydroquinazolin-3-yl)piperidine-1-carboxamide | [Molecular Formula]
C38H47Br2N9O5 | [MDL Number]
MFCD07772306 | [MOL File]
204697-65-4.mol | [Molecular Weight]
869.65 |
| Chemical Properties | Back Directory | [Boiling point ]
1091.9±65.0 °C(Predicted) | [density ]
1.497 | [storage temp. ]
Store at -20°C | [solubility ]
≥87 mg/mL in DMSO with gentle warming; insoluble in EtOH; insoluble in H2O | [form ]
Powder | [pka]
6.80±0.25(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
Olcegepant is a potent and selective calcitonin gene-related peptide (CGRP) receptor antagonist. Olcegepant displays high affinity for human CGRP receptors and exhibits no significant affinity for 75
other receptors. Olcegepant may a be viable option for the treatment of acute migraines. | [target]
CGRP1 | [storage]
Store at -20°C |
|
|